Language selection

Search

Patent 2333601 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2333601
(54) English Title: SURFACTANT FOR USE IN EXTERNAL PREPARATIONS FOR SKIN AND EXTERNAL PREPARATION FOR SKIN CONTAINING THE SAME
(54) French Title: TENSIOACTIF POUR PREPARATION A USAGE EXTERNE DE SOIN DE LA PEAU, PREPARATION A USAGE EXTERNE DE SOIN DE LA PEAU CONTENANT CE TENSIOACTIF
Status: Expired
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61K 8/64 (2006.01)
  • A61K 8/37 (2006.01)
  • A61Q 17/00 (2006.01)
(72) Inventors :
  • YONEDA, TADASHI (Japan)
  • KATO, EIKO (Japan)
  • TSUZUKI, TOSHI (Japan)
  • FURUYA, KAZUO (Japan)
  • TAKAMA, MICHIHIRO (Japan)
  • MIYOTA, YOSHIAKI (Japan)
  • ITO, SHINOBU (Japan)
(73) Owners :
  • KANEKA CORPORATION (Japan)
(71) Applicants :
  • SHOWA DENKO K.K. (Japan)
(74) Agent: SIM & MCBURNEY
(74) Associate agent:
(45) Issued: 2008-02-05
(86) PCT Filing Date: 1999-05-28
(87) Open to Public Inspection: 1999-12-09
Examination requested: 2004-05-18
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/JP1999/002858
(87) International Publication Number: WO1999/062482
(85) National Entry: 2000-11-28

(30) Application Priority Data:
Application No. Country/Territory Date
10/149088 Japan 1998-05-29
11/71048 Japan 1999-03-16

Abstracts

English Abstract




Disclosed are a surfactant for use in external preparations for skin including
a lipopeptide compound derived from prokaryotes
and having low skin penetration and low irritation to the skin, an external
preparation for skin containing such a surfactant, such as a
cosmetic, and an external preparation for skin, such as a transparent
cosmetic, e.g., a transparent cosmetic containing such a surfactant and
a sequestering agent.


French Abstract

Cette invention, qui a trait à un tensioactif utilisé dans des préparations à usage externe de soin de la peau comportant un composé lipopeptide dérivé de protocaryotes, ne pénétrant que légèrement dans la peau et ne l'irritant pas, concerne également une préparation à usage externe de soin de la peau contenant ce tensioactif, un cosmétique notamment, et une préparation à usage externe pour la peau, un cosmétique transparent notamment, par exemple, un cosmétique transparent contenant ce tensioactif et un agent chélateur.

Claims

Note: Claims are shown in the official language in which they were submitted.




The embodiments of the invention in which an exclusive
property or privilege is claimed are defined as follows:

1. An external preparation for skin comprising a
lipopeptide compound or its salt, and a skin-irritating
substance, wherein the lipopeptide compound is at least one
compound represented by formula (2) below

Image
(wherein X1 is an amino acid selected from the group
consisting of leucine, isoleucine, valine, glycine, serine,
alanine, threonine, asparagine, glutamine, aspartic acid,
glutamic acid, lysine, arginine, cystein, methionine,
phenylalanine, tyrosine, tryptophan, histidine, proline,
4-hydroxyproline, and homoserine, and R has 9 to 13 carbon
atoms and is a n-alkyl group, an isoalkyl group, or an
anteisoalkyl group).

2. The external preparation for skin as claimed in claim
1, wherein X1 is leucine, isoleucine or valine.

3. The external preparation for skin as claimed in claim
1 or 2, wherein the lipopeptide compound or its salt has an
effect of inhibiting the skin penetration of the skin-
irritating substance.

4. The external preparation for skin as claimed in claim
1 or 2, wherein the lipopeptide compound or its salt has an
effect of inhibiting the skin penetration of the skin-
irritating substance and reduces irritation of the skin-
irritating substance.



68



5. The external preparation for skin as claimed in claim
4, wherein the skin-irritating substance is an antiseptic.
6. The external preparation for skin as claimed in claim
5, wherein the antiseptic is a paraben compound.

7. The external preparation for skin as claimed in any
one of claims 1 to 6, wherein the lipopeptide or its salt in
a content of 0.01 to 30 wt%.

8. The external preparation for skin as claimed in any
one of claims 1 to 7, further comprising a sequestering
agent.

9. The external preparation for skin as claimed in claim
8, wherein the lipopeptide compound or its salt is in a
content of 0.01 to 30 wt% and the sequestering agent is in a
content of 0.0001 to 30 wt%.

10. A cosmetic comprising an external preparation for skin
as claimed in any one of claims 1 to 9.



69

Description

Note: Descriptions are shown in the official language in which they were submitted.



CA 02333601 2000-11-28

DESCRIPTION -

Surf actant for use in external preparations for skin and
external preparation for skin containing the same

TECHNICAL FILED

The present invention relates to a surfactant for
use in external preparations for skin and to an external
preparation for skin containing it. More particularly,
the present invention relates to a surf actant for use
in external preparations for skin having low skin

permeability (penetrability) and low irritation, an
external preparation for skin, such as cosmetic,
containing such a surfactant, and an external
preparation for skin, such as a transparent cosmetic,

containing such a surfactant and a sequestering agent.
BACKGROUND ART

Hitherto, in external preparations for skin, such
as cosmetics, there have been used anionic surfactants
composed of aliphatic higher alcohol sulfates,

aliphatic higher alcohol phosphates, N-long chain acyl
glutaminates, etc., ether type nonionic surfactants,
e.g., aliphatic higher alcohol ethylene oxide adducts,
nonionic surfactants composed of higher fatty acid and
polyhydric alcohols, as emulsifiers, dispersants,

solubilizers, etc.

1


CA 02333601 2000-11-28

However, skin irritation of these surfactants
cannot be said to be sufficiently low to individuals who
have allergic constitution, suffering, e.g.,
pollenosis, atopic dermatitis, etc. so that external

preparations for skin containing such have insufficient
safety to skin and improvement thereof has been desired.
Further, even if external preparations for skin are

prepared using surfactants having sufficiently low
irritation to the skin, the external preparations for
skin contain in addition to surfactants irritating

substances such as salicylic acid, paraben or
hexachlorophene as an antiseptic. Therefore, in order
to reduce their irritation to the skin, development of
low irritation external preparations for skin has been
desired.

Known examples of low irritation surfactants
include amino acid derivatives. For example, there have
been proposed basic amino acid derivatives produced by
reacting a glycidyl ether and a basic amino acid

(Japanese Patent Application Laid-open No. Hei 9-271655
(European Patent Application Laid-open
No.788,832(A1)), and certain water-soluble glycoxide
type surfactants as a surfactant having low irritation
and alleviating the irritation of other skin-irritating

substances (Japanese Patent Application Laid-open No.
Hei 9-235587).

2


CA 02333601 2000-11-28

Further, with view to prevent glycine derivatives
from coloring and deterioration, there have been
proposed detergent compositions having blended therein
a metal chelating agent and an antioxidant (Japanese

Patent Application Laid-open Nos. Hei 9-78085, Hei
9-87673, and Hei 10-237488). However, these surfactants
have problems that they are not fully satisfactory in
low irritation, they have low effect of reducing

irritation by irritating substances other than

surf actants, they decrease the surface activity of other
surfactants, their deterioration cannot be prevented
completely, and so on.

DISCLOSURE OF THE INVENTION

Therefore, an object of the present invention is
to provide a surf actant for use in external preparations
for skin, having low irritation to the skin.

Another object of the present invention is to
provide a surfactant for use in external preparations
for skin, not only having low skin irritation to the skin
itself but also reducing the irritation of skin-

irritating substances.

Further, an object of the present invention is to
provide an external preparation for skin, such as a
cosmetic, containing the above-described surf actant for

use in external preparations for skin.
3


CA 02333601 2000-11-28
1 ~

Furthermore, an object of the present invention is
to provide an external preparation for skin containing
the above-described surfactant for use in external
preparations for skin, retaining transparency for

cosmetics required of transparency.

The present inventors have made intensive research
with view to achieving the above-described objects and
as a result they have found that when used as a
surfactant, a compound produced by fermentation by

prokaryotes such as Bacillus microbes is low in skin
penetrability, is low in irritation to the skin and,
surprisingly, has an effect of reducing the irritation
by skin-irritating substances.

Further, the present inventors have found that
existence of a minute amount of an alkaline earth metal
such as calcium or magnesium in external preparations
for skin containing the above-described surfactant
results in that the surfactant and the alkaline earth
metal form a water-insoluble salt, which precipitates

and make the preparation turbid whereas blending a
sequestering agent together with the surfactant in the
external preparation for skin prevents the formation of
the water-insoluble salt of the surfactant without
affecting the low irritation of the surfactant and the

effect of reducing the irritation of skin-irritating
4


CA 02333601 2000-11-28

substances, so that transparency of the preparation can
be retained.

Based on these findings, the present invention
provides a surfactant for use in external preparations
for skin, an external preparation for skin, and a

cosmetic as described below.

[1] A surfactant for use in external preparations for
skin comprising a compound derived from a prokaryote.
[ 2] The surfactant for use in external preparations for

skin as described in item 1 above, wherein the prokaryote
is a Bacillus microbe.

[ 3] The surfactant for use in external preparations for
skin as described in item 1 above, wherein the compound
derived from prokaryote is a lipopeptide compound or its
salts.

[ 4] The surfactant for use in external preparations for
skin as described in item 3 above, wherein the
lipopeptide compound is at least one compound
represented by formula (2) below

RCHCH2CO-L_GIu-Lleu-p_Leu-L_Val-LAsp-p_Leu-L_C
0 1

(wherein X1 is an amino acid selected from the group
consisting of leucine, isoleucine, valine, glycine,
serine, alanine, threonine, asparagine, glutamine,
aspartic acid, glutamic acid, lysine, arginine,

5


CA 02333601 2000-11-28

cystein, methionine, phenylalanine, tyrosine,
tryptophan, histidine, proline, 4-hydroxyproline, and
homoserine, and R has 9 to 13 carbon atoms and is a
n-alkyl group, an isoalkyl group, or an anteisoalkyl
group).

[ 5] The surfactant for use in external preparations for
skin as described in item 4 above, wherein X1 is leucine,
isoleucine or valine.

[ 6] The surfactant for use in external preparations for
skin as described in item 3 above, wherein the
lipopeptide compound is plipastatin, arthrofactin,
iturin, or serrawettin.

[ 7] The surfactant for use in external preparations for
skin as described in any one of items 1 to 6 above,
wherein the surfactant has an effect of inhibiting the

skin penetration of a skin-irritating substance.

[ 8] The surfactant for use in external preparations for
skin as described in any one of items 1 to 6 above,
wherein the surfactant has an effect of inhibiting the

skin penetration of a skin-irritating substance and
reduces irritation of a skin-irritating substance.

[ 9] The surfactant for use in external preparations for
skin as described in item 8 above, wherein the skin-
irritating substance is an antiseptic.

6


CA 02333601 2000-11-28

[ 10 ] The surfactant for use in external preparations for
skin as described in item 9 above, wherein the antiseptic
is a paraben compound.

[11] An external preparation for skin comprising a

surf actant for use in external preparations as described
in any one of items 1 to 10 above.

[12] The external preparation for skin as described in
item 11 above, wherein the surfactant for use in external
preparations for skin is in a content of 0.01 to 30 wt%.

[131 The external preparation for skin as described in
item 11 or 12 above, further comprising a sequestering
agent.

[141 The external preparation for skin as described in
item 13 above, wherein the surfactant for use in external
preparations for skin is in a content of 0.01 to 30 wt%

and the sequestering agent is in a content of 0.0001 to
30 wt%.

[15] A cosmetic comprising an external preparation for
skin as described in any one of items 11 to 14 above.

DETAILED DESCRIPTION OF THE INVENTION

The present invention is based on the discovery that
a lipopeptide compound derived from a prokaryote has a
low irritation to the skin and reduces the irritation

of skin-irritating substances and has applied this to
a surfactant for use in external preparations for skin.
7


CA 02333601 2000-11-28

Typical examples of the lipopeptide compound
derived from a prokaryote includes surfactin. Surfactin
is a compound, which is produced usually by a prokaryote,
has a lipopeptide structure represented by the formula
1 below.

RCHCH2CO-L_GIu-L_Leu-p_Leu-L_Vai-LAsp-p_Leu-L_X
O

wherein X is leucine, isoleucine or valine, R has 9 to
13 carbon atoms and represents a n-alkyl group, an
isoalkyl group or an anteisoalkyl group.

Generally, Bacillus microbes are used as the

prokaryote. Specific examples thereof include Bacillus
subti.lis IAM 1213 strain, IAM 1069 strain, IAM 1259
strain, IAM 1260 strain, IFO 3035 strain, ATCC 21332
strain, etc.

Surfactin can be obtained without difficulty by
cultivating these microbes and purifying lipopeptide
compounds that the microbes produced. Purification can
be performed, for example, by rendering the culture
broth acidic by addition of hydrochloric acid, etc.,
filtering surfactin which precipitated, dissolving the

precipitate in an organic solvent such as methanol, and
then optionally practicing ultrafiltration, treatment
with activated carbon, crystallization, etc.
Precipitation by addition of an acid may be replaced by

8


CA 02333601 2000-11-28
1 i
precipitation by addition of a calcium salt (Biochem.
Bioph. Res. Commun., 31: 488-494 (1968)).

Compounds having a lipopeptide structure derived
from prokaryotes, other than surfactin, may be used
similarly. Examples of such compounds include

plipastatin (J. Antibiot., Vol. 39, No. 6, 745-761,
1986), arthrofactin (J. Bacteriol., Vol. 175, No. 20,
6459-6466, 1993), iturin (Biochemistry, Vol. 17, No. 19,
3992-3996, 1978, serrawettin (J. Bacteriol., Vol. 174,
No. 6, 1769-1772, 1992).

Plipastatin
R-L.GIu- aOrn-L_Tyr -p_aiio_Thr -L_Glu-p_Y-L_Pro-L_Gln- p_Tyr - L_I le
1 0
~
(wherein Y is Val or Ala and Orn stands for ornithine. )

Arthrofactin
CH3(CH2)sCHCH2CO -p_Leu-aAsp-aThr-aLeu-p_Leu-aSer-L_Leu-aSer- L_Ile-L_Ile-
L.Asp
~ 0 ~
Iturin

CH3CH(CH2)9CHCH2CO-LAsn-p_Tyr-LAsn-L_Gln-L_Pro-oAsn-L_Ser
CH3 I H (
9


CA 02333601 2000-11-28
Serrawettin

CH3(CH2)6CHCH2CO -aLeu-L_Ser-L_Thr-p_Phe-L_IIe
Hereafter, the present invention will be described
specifically referring to surfactin as a typical
example.

Surf actin generally comprisesat least one compound
represented by the formula 1 above.

In the formula 1, of the groups having 9 to 13 carbon
atoms represented by R, the n-alkyl group is a straight
chain alkyl group, the isoalkyl group usually has the

structure ( CH3 ) 2CH- ( CH2 ) n- , and the anteisoalkyl group
usually has the structure CH3-CH2-CH ( CH3 )-( CHZ ) n- .
When surf actin is utilized, the culture broth may

be used as it is or purified before it can be used.
As will be apparent from the formula 1, surfactin
may be used as a metal salt or organic ammonium salt of

a carboxyl group derived from the amino acid structural
unit. The metal which serves as a counter ion may be
any types of metals so far as they form a salt with
surfactin, not to speak of alkali metals such as sodium,

potassium, and lithium, alkaline earth metals such as
calcium and magnesium. The organic ammonium includes
trimethylamine, triethylamine, tributylamine,
monoethanolamine, diethanolamine, triethanolamine,

--- - ----- -- ---- - ----


CA 02333601 2000-11-28
1 i

lysine, arginine, choline, etc. Among them, preferred
are alkali metal salts, particularly sodium salt.
Surfactin shows an anion activity due to the
carboxyl group of L-Glu (L-glutamic acid), L-Asp (L-

aspartic acid) therein.

The low irritation to the skin of surfactin is
considered to be attributable to the fact that surf actin
is a cyclic compound of a complexed structure and bulky
so that it has a low skin penetrability. Also, surfactin
is considered to reduce the irritation of skin-

irritating substances because of its masking effect by
surrounding the skin-irritating substances.

Further, the present invention provides an external
preparation for skin by utilizing surfactin as a

surf actant for use in external preparations for skin and
blending it together with a sequestering agent to retain
transparency.

In the present invention, the surfactant for use
in external preparations for skin used has a low skin
penetrability and is expected to exhibit the above-

described masking effect.

Further, those compounds based on surfactin but
with varied amino acid composition, for example, X in
the formula 1 is substituted by glycine, serine,

alanine, threonine, asparagine, glutamine, aspartic
acid, glutamic acid, lysine, arginine, cystein,

11


CA 02333601 2000-11-28
I

methionine, phenylalanine, tyrosine, tryptophan,
histidine, proline, 4-hydroxyproline, and homoserine,
the compound of the formula 2 above, may also be used.

Surfactin and the above-described compounds may
also be those obtained by other methods, for example,
chemical synthesis, as well as those derived from
prokaryotes such as Bacillus microbes, and can be used
similarly.

The sequestering agent used in the present
invention will be explained below.

If metal ions exist in transparent external
preparations for skin, they cause deterioration of the
quality of external preparations for skin, such as
generation of turbidity or precipitation. The

sequestering agent is used for the purpose of preventing
such.

The sequestering agent which can be used in the
present invention may be of any type so far as it has
an acidic group having a salt-forming ability or an

atomic group having an ability of coordination and can
sequester metal ions. Specific examples of the
sequestering agent includes L-alanine, DL-alanine,
trisodium ethylenediaminehydroxyethyltriacetate,
trisodium ethylenediaminehydroxyethyltriasetate

dihydrate, edetic acid, dipotassium edetate dihydrate,
disodium edetate, disodium calcium edetate, trisodium
12


CA 02333601 2000-11-28

edetate, tetrasodium edetate, tetrasodium edetate
dihydrate, tetrasodium edetate tetrahydrate, sodium
citrate, gluconic acid, sodium gluconate, tartaric
acid, phytic acid, sodium polyphosphate, sodium

metaphosphate, tetrasodium L-glutaminate diacetate,
etc.

These may be used singly or two or more of them may
be used simultaneously.

Of these, disodium edetate and sodium citrate are
particularly preferred.

The sequestering agent forms salts with alkaline
earth metals such as calcium and magnesium so that it
prevents the formation of salts between surfactin and
alkaline earth metals.

The external preparation for skin of the present
invention contains the above-described surfactant or
the above-described surfactant and sequestering agent.
In the external preparations for skin, the surfactant
used in the present invention serves as an emulsifier,
a dispersant, a solubilizer, a wetting agent, a

detergent, a humectant, etc. and also acts as an
irritation-reducing agent for skin-irritating
substances. There is no limitation on the form in which
the surf actant is contained in external preparations for

skin, which may be achieved by any one of dissolution,
emulsification, dispersion, mixing, etc. and may be in
13


CA 02333601 2000-11-28
I

any form such as liquid, milky lotion, gel, solid
(inclusive of powder and granules). It may be in the
state where vesicles are formed in a solution.

The amount of surfactant in external preparations
for skin is generally in a range of 0.01 to 30 wt$ . The
amount of sequestering agent is generally equivalent to
or larger than the amount of the alkaline earth metal
contained in the external preparation for skin, which
gives sufficient effects . More specifically, it may be

used in a range of 0.0001 to 3 wt%, preferably 0.001 to
0.2 wt%.

A typical example of external preparations for skin
is a cosmetic. Specific examples thereof include skin
milk, skin cream, foundation cream, massaging cream,

cleansing cream, shaving cream, cleansing foam, a beauty
wash, lotion, pack, shampoo, rinse, a hair restoration
agent, a hair tonic, a hair dye, a hair dressing,
dentifrice, a gargle, permanent waving agent, ointment,
bath additive, body soap, etc. Any type of external

preparations for skin may be included so far as it is
brought in contact with the skin when in use. Sex and
age of users are irrelevant.

The skin-irritating substances whose irritation is
reduced by the surfactant for use in external

preparations for skin according to the present invention
includes antiseptics, ultraviolet absorbents,

14


CA 02333601 2000-11-28

antioxidants, dyes, beautifying and whitening agents,
hair dyes, perfumes, alcohols, metal soaps, surfactants
other than those of the invention, and so on.

Hereafter, specific examples thereof will be

described. In particular, the surf actant of the present
invention is effective in reducing the irritation of
paraben compounds, which are antiseptics.
Skin-irritating substances:

Bacteriocidal antiseptics such as salicylic acid,
paraben compounds (methylparaben, propylparaben,
butylparaben, ethylparaben, etc.), hexachlorophene,
imidazolidinylurea, quaternium-15, DM hydantoin,
phenoxyethanol, and benzalkonium salts.

Sun screening agents such as p-aminobenzoic acid,
antioxidants such as dibutylhydroxyltoluene,
butylhydroxyanisole and alkyl gallates, para-amino
acids such as 2-hydroxy-4-methoxybenzophenone,
octyldimethyl-p-aminobenzoate, and ethylhexyl-p-
methoxycinnamate, organic ultraviolet absorbents such

as hydroxybenzophenone-base, benzofuran-base,
salicylic acid-base, coumarin-base, azole-base
ultraviolet absorbents.

Ultraviolet rays reflection scattering agent such
as titanium oxide, kaolin, and talc.

Vitamin agents such as vitamin A, C, E.


CA 02333601 2000-11-28

Pigments such as talc, kaolin, calcium carbonate,
magnesium carbonate, magnesium silicate, silicic
anhydride, titanium oxide, zinc oxide, red iron oxide,
yellow iron oxide, chromium oxide, chromium hydroxide,

carbon black, ultramarine, bismuth oxychloride, mica
titanium mineral, and mica and organic and tar-base dyes
such as butter yellow.

Beautifying and whitening agents such as kojic
acid, albutin, mulberry root bark, placenta extract, SS
albutin, ellagic acid, chamomile extract, and ascorbic
acid derivatives.

Hair dyes such as oxidative dyes and acidic dyes
and color aids, e.g., 5-amino-o-cresol, 2-amino-4-
nitrophenol, 2-amino-5-nitrophenol, 1-amino-4-

methylaminoanthraquinone, 3,3'-iminodiphenol, 2,4-
diaminophenoxyethanol hydrochloride, 2,4-
diaminophenol hydrochloride, toluene-2,5-diamine
hydrochloride, nitro-p-phenylenediamine
hydrochloride, p-phenylenediamine hydrochloride, N-

phenyl-p-phenylenediamine hydrochloride, m-
phenylenediamine hydrochloride, o-aminophenol,
catechol, N-phenyl-p-phenylenediamine acetate, 1,4-
diaminoanthraquinone, 2,6-diaminopyridine, 1,5-
dihydroxynaphthalene, diphenylamine, ammonium

carbonate, toluene-2,5-diamine, toluene-3,4-diamine,
a-naphthol, nitro-p-phenylenediamine, p-aminophenol,
16


CA 02333601 2000-11-28

p-nitro-o-phenylenediamine, p-phenylenediamine, p-
methylaminophenol, picramic acid, sodium picramate,
N,N-bis(4-aminophenyl)-2,5-diamino-1,4-quinone-
diimine, 5-(2-hydroxyethylamino)-2-methyiphenol,

sodium 2-hdryoxy-5-nitro-2',4'-diaminoazobenzene-5-
sulfonate, hydroquinone, pyrogallol, N-phenyl-p-
phenylenediamine, phloroglucin, hematein, gallic acid,
m-aminophenol, m-phenylenediamine, 5-amino-o-cresol
sulfate, 2-amino-5-nitrophenol sulfate, o-aminophenol

sulfate, o-chloro-p-phenylenediamine sulfate, 4,4'-
diaminodiphenylamine sulfate, 2,4-diamminophenol
sulfate, toluene-2,5-diamine sulfate, nitro-p-
phenylenediamine sulfate, p-aminophenol sulfate, p-
nitro-o-phenylenediamine sulfate, p-nitro-m-

phenylenediamine sulfate, p-phenylenediamine sulfate,
p-methylaminophenol sulfate, m-aminophenol sulfate,
m-phenylenediamine sulfate, etc.

Perfumes such as sesquiterpene alcohol, geraniol,
and linalool.

pH adjusting agent, buffer, or chelating agent,
e.g., disodium edetate, ethylenediaminetetraacetic
acid salts, pyrophosphoric acid salts,
hexametaphosphoric acid salts, tartaric acid, gluconic
acid, sodium hydroxide, triethanolamine, citric acid,

sodium citrate, boric acid, borax, potassium hydrogen
phosphate, etc.

17


CA 02333601 2000-11-28

Astringent such as zinc p-phenolsulfonate.
Alcohols such as ethanol and isopropanol.

Metal soaps such as magnesium, calcium and aluminum
stearates, zinc laurate, and zinc palmitate.

In the external preparation for skin of the present
invention, known synthetic surfactant may be used in
combination and also the irritation of the surfactant
can be reduced.

The surfactant in this case include, for example,
nonionic surfactants such as oleophilic glycerin
monostearate, self-emulsifying glycerin monostearate,
polyglycerin monostearate, sorbitan monooleate,
polyethylene glycol monostearate, polyoxyethylene
sorbitan monooleate, polyoxyethylene cetyl ether,

polyoxyethylenated sterol, polyoxyethylene alkyl
ether, polyoxyethylene fatty acid ester,
polyoxyethylene sorbitan fatty acid ester,
polyoxyethylenated lanolin, poloxyethylenated beeswax,
and polyoxyethylene-hardened castor oil, anionic

surfactants such as sodium stearylphosphate, potassium
palmitate, sodium cetylsulfate, sodium
laurylphosphate, triethanolamine palmitate, sodium
polyoxyethylene laurylphosphate and sodium N-
acylglutaminate, cationic surfactants such as.

stearyldimethylbenzylammonium chloride and
stearyltrimethylammonium chloride, amphoteric
18


CA 02333601 2000-11-28

surfactants such as alkylaminoethylglycine
hydrochloride liquid, and lecithin.

As other irritating substances, among oils and
fats, oxidized lipids and lipid peroxides may be

irritants. For example, it is when lipids as set forth
below are oxidized.

There can be cited, for example, plant oils and fats
such as castor oil, olive oil, cacao oil, camellia oil,
coconut oil, haze wax, jojoba oil, grape seed oil,

avogado oil, beefsteak plant oil, perilla oil, animal
oils and fats such as mink oil, yolk oil,
eicosapentaenoic acid (EPA), and docosahexaenoic acid
(DHA), waxes such as beeswax, spermaceti, lanolin,
carnauba wax, and candelilla wax, hydrocarbons such as

liquid paraffin, squalane, microcrystalline wax,
ceresin wax, paraffin wax, and vaseline, natural and
synthetic fatty acids such as lauric acid, myristic
acid, stearic acid, oleic acid, isostearic acid, and
behenic acid, natural and synthetic higher alcohols such

as cetanol, stearyl alcohol, hexyldecanol,
octyldodecanol, and lauryl alcohol, esters such as
isopropyl myristate, isopropyl palmitate, isopropyl
adipate, octyldodecyl myristate, octyldodecyl oleate,
and cholesterol oleate.

Also, permanent waving agent such as thioglycollic
acid includes irritants.

19


CA 02333601 2000-11-28

In addition, there can be cited those substances
which are converted into irritants during storage or use
by physical, chemical or biological effects, for
example, peroxides or various irritating decomposates.

However, this invention is not limited thereto.

In addition to the above-described skin-irritating
substances, the external preparation for skin of the
present invention may contain usually used components
such as surfactants, humectants, thickening agent,

antiphlogistics, plant extract components, and other
components as described below.

Examples of surfactant include sodium
monofluorophosphate, fatty acid salts,
alkylbenzenesulfonates, alkylnaphthalenesulfonates,

alkylsulfonates, a-olefinsulfonates,
dialkylsulfosuccinates, a- sulfonated fatty acid salts,
alkylsulfates, polyoxyethylene alkyl ether sulfates,
polyoxyethylene alkyl phenyl ether sulfates,

polyoxyethylene styrenated phenyl ether sulfates,
alkylphosphates, polyoxyethylene alkyl ether
phosphates, polyoxyethylene alkyl phenyl ether
phosphate, naphthalenesulfonate formalin condensate,
polyoxyethylene alkyl ether, polyoxyethylene alkyl
phenyl ether, polyoxyethylene polystyryl phenyl ether,

polyoxyethylene polyoxypropylene glycol,
polyoxyethylene polyoxypropylene alkyl ether,


CA 02333601 2000-11-28

polyhydric alcohol fatty acid partial ester,
polyoxyethylene polyhydric alcohol fatty acid partial
ester, polyoxyethylene fatty acid ester, polyglycerin
fatty acid ester, polyoxyethylenated castor oil, fatty
acid diethanolamide, polyoxyethylene alkylamine,

triethanolamine fatty acid partial ester, trialkylamine
oxide, fatty acid amine salt, tetraalkylammonium salt,
trialklbenzylammonium salt, alkylpyridinium salt, 2-
alkyl-l-alkyl-l-hydroxyethylimidazolium salt, N,N-

dialkylmorpholinium salt, polyethylene polyamine fatty
acid amide salt, etc.

Examples of humectant includes polyhydric
alcohols, such as glycerin, propylene glycol, 1,3-
butylene glycol, sorbitol, polyglycerin, polyethylene

glycol, and dipropylene glycol, natural moisturizing
factor (NMF) components such as amino acids and sodium
lactate, water-soluble polymers such as collagen,
mucopolysaccharide and chondroitinsulfate, moisture-
conditioner/humectants such as maltitol, sodium

pyrolidonecarboxylate, polyoxyethylene methyl
glucoside, hyaluronic acid, hyaluronic acid
derivatives, ceramide, ceramide derivatives, ceramide
analogues, and glucose.

Examples of thickening agent include natural

polymers such as sodium alginate, xanthan gum, quince
seed gum, tran gum, bee gum, pectin, alginates,

21


CA 02333601 2000-11-28

laponite, aluminum silicate, quince seed extract,
tragacanth gum, and starch, semi-synthetic polymers
such as methylcellulose, hydroxyethylcellulose,
carboxymethylcellulose, soluble starch, and cationated

cellulose, synthetic polymers such as acrylic polymer
and polyvinyl alcohol, etc.

Antiphlogistics include salicylic acid derivative
type antiphlogistics, aniline derivative type
antiphlogistics, spasmolysants, pyrazolone derivative

type antiphiogistics, indomethacin antiphlogistics,
mephenamic acid antiphlogistics, anti-histamin agent,
anti-allergy agent, anti-inflammatory enzyme agent,
steroid agent, glycyrrhizin, azulene, allantoin, etc.

Combined use of these antiphlogistics will promote
antiphlogistic effect on wound. Their usage may be
generally on the order of 0.001 to 10 mol/l (external
preparation for skin).

Plant extract components include triclosan
(Irgasan-DP300 available from Ciba-Geigy Co., Ltd.),
glycyrrhizic acid or its sodium or potassium salt or

other salts, triethanolamine, hinoki extract,
hinokithiol, edetates, propylene glycol, beefsteak
plant extract, rosemary extract, rose extract,
chamomile extract, Melissa extract, sage extract,

licorice extract, jojoba extract, N-acyl-L-glutamic
acid or its sodium salt or other salts, cetanol,

22


CA 02333601 2000-11-28

Sappiness mukorossi extract, squalanes such as plant
squalane, etc.

Other components include nutrients such as amino
acids and amino acid derivatives, emolients such as
ester oils and higher alcohols, abrasives such as

calcium phosphate, aluminum hydroxide, calcium
pyrophosphate, and insoluble sodium metaphosphate,
ultraviolet absorbents, ultraviolet scattering agents,
and those components which are described in the

following raw material lists (1) to (8).

(1) Cosmetics raw material nonstandardized components
standard (Yakuji Nippo, published October 14, 1993,
pages 39-1368)

(2) Japan general use cosmetics raw material list, 2nd
ed. (Yakuji Nippo, published March 25, 1989, pages
1-509)

(3) Japanese general use cosmetics raw material list,
3rd ed. (Yakuji Nippo, published June 30, 1994, pages
1-612)

(4) Medical drugs Japanese medicines, 21st ed. (Yakuji
Nippo, published 1997, pages 1-2100)

(5) General drugs Japanese medicines, 1998-99 (Yakuji
Nippo, November 10, 1997)

(6) 13th Revised Japan Pharmacopoeia First Supplement
(Yakugyo Jiho, published January 31, 1998, pages 58-
190)

23


CA 02333601 2000-11-28
I 1

(7) List of laws and ordinances relating to existing
additives register associated with amendment of food
hygiene law (edited by Food chemistry section, life
hygiene bureau, Ministry of Commonwealth, published

July 10, 1996, Social Insurance Publishers, pages 5-
221)

(8) List of standards on the components of food
additives, 8th ed. (Japan Science Feeding Stuff
Association, published November 18, 1996, pages 7-827).

The surfactants, humectants, thickening agents,
antiphlogistics, plant extracts components and other
blending components may be added solely or in

combination. There is no limitation on the addition
amount thereof but usually they may be added in

preparations in amounts in a range of 0.0001 to 80 wtt.
BEST MODE FOR CARRYING OUT THE INVENTION

Next, the present invention will be described in
further detail by examples and formulations. However,
the present invention should not be construed as being
limited thereto. In the following examples, all 't"
means 'wt$" unless other indicated specifically as in
the case of toxicity, for example.


24


CA 02333601 2000-11-28
1 !
Production Example

Bacillus subtilis ATCC 21332 strain was inoculated
in a medium (1$ polypeptone, 0.1% RHZPO4, 0.05%

MgSO4 '7H2O, adjusted with NaOH to pH 7, balance water)
and incubated at 35'C at 160 rpm for 12 hours. 100 ml
of the culture medium was inoculated into a 2-liter
fermenter charged with a medium containing soybean
powder and maltose as main components and potassium
hydrogen phosphate, magnesium sulfate, calcium salt,

iron salt, and manganese salt as inorganic salts, and
incubated at 35r with stirring and strong aeration for
48 hours. During the incubation, caustic soda was added
to maintain the medium at pH 7.0 to 7. 5. After completion
of the incubation, the medium was centrifuged to remove

the bacteria cells and the resultant culture supernatant
was collected. A portion of the culture supernatant was
freeze-dried to obtain a dried medium preparation. The
remaining culture supernatant was adjusted with

hydrochloric acid to pH 2 to precipitate a surfactin
fraction. The supernatant was removed by centrifugation
and the surfactin fraction was dissolved in an acetone
organic solvent. The resultant solution was passed
through ultrafiltration membrane resistant to organic
solvents (Cefilt UF10,000, a ceramic membrane filter

manufactured by Nippon Gaishi) to recover a liquid
fraction, thereby removing high molecular weight


CA 02333601 2000-11-28

impurities. Then, to the liquid fraction was added
activated carbon (~ 20 m) to deodorize and decolorize
it. Thereafter, the activated carbon was removed by
filtration and the filtrate was concentrated to dryness

in an evaporator. Then, the resulting solids were
dissolved in water while adding caustic soda thereto to
maintain the pH around 7. The resultant solution was
freeze-dried to obtain purified surfactin sodium salt
powder. The dried medium preparation and surfactin

sodium salt were used in the following tests.
Surface tension tests

The dried medium preparation and purified surf actin
sodium salt were each dissolved in water in an amount
of 0.1 wt$ and their ability of decreasing surface

tension was tested. Surface tension was measured by a
plate method (25r-) using an automatic surface tension
meter CBVP-Z type manufactured by Kyowa Kaimen Kagaku
Co., Ltd. Table 1 shows the results.

Table 1: Surface Tension
Water 72.1 mN/m
Aqueous solution of dried 28.4 mN/m
medium preparation (0.1 wt%)

Aqueous solution of purified 27.6 mN/m
surfactin sodium (0.1 wt$)

26


CA 02333601 2000-11-28
i

Example 1: Skin irritation test of surfactant

Using a three-dimensional skin model (trade name:
Three-dimensional cultured skin model, manufactured by
Gunze), skin irritation tests were performed. As the

test substances were used the surfactin sodium salt and
dried medium preparation of the Production Example
above, and SDS (sodium dodecylsulfate), Amisoft LS-11
(manufactured by Ajinomoto, hereafter, referred to as
Amisoft). The test substances were adjusted with PBS

(Phosphate Buffer Saline, pH 7) so that they were in
various concentrations. To the thus-adjusted test
substances was exposed the skin model for 1 hour.
Thereafter, the test substances were washed and
incubated for 16 hours in a medium attached to the

above-described three-dimensional skin model. After
the incubation, a solution of MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) was added and pigments were extracted with
isopropanol rendered acidic with hydrochloric acid,

followed by measurement of absorbance at a wavelength
of 570 nm. This value was called A. Also, as a control,
similar operations were repeated without addition of
test substances and absorbance at a wavelength of 570
nm was measured. This value was called B. The MTT

solution was added to PBS and extraction was performed
similarly. Absorbance of the extract measured at a
27


CA 02333601 2000-11-28
I i

wavelength of 570 nm was named C. From these values was
calculated cytotoxicity. Calculation was made
according to the following equation.

Cytotoxicity (t) = (1-(A-c)/(B-C)) x 100

Plotting the concentration of a test substance on
the axis of abscissa and cytotoxicity on the axis of
ordinate, a graph was obtained, from which the
concentration of a test compound at 50% cytotoxicity was
read. Whether this value is large or small indicates

whether skin irritation is strong or weak. Table 2 shows
concentrations at 50% cytotoxicity.

Table 2

Surfactant Concentration of surfactant
at 50% cytotoxicity
Surfactin sodium salt 24.4 %
Dried medium preparation 32.8 %
Amisoft 2.7 %
SDS 0.2 $

As shown in Table 2, it is apparent that the

surfactin sodium salt and dried medium preparation of
the inventive product exhibited very low skin irritation
as compared with Amisoft and SDS, respectively.
Example 2: Skin penetration test of skin-irritating
substances

28


CA 02333601 2000-11-28

One (donor side) of two chambers separated by a
hairless mouse skin was filled with a phosphate buffer
(pH 7) having dissolved therein a substance having the
composition described in Table 3 and the other (receiver

side) was filled with a phosphate buffer solution (pH
7). After 5 hours, the concentration of methylparaben
on the receiver side was measured. Table 3 shows the
results. As will be apparent from the results, surfactin
suppressed the skin penetration of skin-irritating

substances.

Table 3

Composition on donor side Concentration of
methylparaben of receiver
0.1% Methylparaben 5.7 ppm
0.1% Methylparaben
+ 1% Surfactin sodium salt 3.6 ppm
0.1% Methylparaben 3.8 ppm
+ 1% dried medium preparation

0.1% Methylparaben + 1$ SDS 23.0 ppm
Example 3: Skin irritation tests with external
preparation for skin - 1

Milky lotions having the respective compositions
shown in Table 4 were prepared by a conventional method
and were evaluated for their skin irritation. In the
same manner as in Example 1, a skin model was exposed
to each of the prepared test substances (milky lotions
described in Table 4) for 1 hour. Thereafter, the test
29


CA 02333601 2000-11-28
1 1

substance was washed and incubated in the above-
described medium for 16 hours. After the incubation,
a MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) was added, and pigments

were extracted with isopropanol rendered acidic with
hydrochloric acid, followed by measurement of
absorbance and calculation of cytotoxicity. The
cytotoxicity was calculated according to the equation
described in Example 1.

Table 5 shows the cytotoxicity of each test
substance.

Table 4

Inventive Comparative
Component($) preparation preparation
1 2 1 2
Surfactin sodium salt 3.0 - - -
Dried medium preparation - 3.0 - -
Amisoft
- - 3.0 -
SDS - - - 3.0
Avogado oil 11.0 11.0 11.0 11.0
Behenyl alcohol 0.6 0.6 0.6 0.6
Stearic acid 0.4 0.4 0.4 0.4
1,3-Butylene glycol 10.1 10.1 10.1 10.1
Perfume 0.4 0.4 0.4 0.4
Purified water Balance Balance Balance Balance



CA 02333601 2000-11-28
1 i

Table 5

Test Substance Cytotoxicity
Inventive preparation 1 0.0%
Inventive preparation 2 0.0%
Comparative preparation 1 72.5%
Comparative preparation 2 98.5$

As will be apparent from the results in Table 5,
the inventive preparation had very low irritation to the
skin.


Example 4: Skin irritation tests with external
preparation for skin - 2

One (donor side) of two chambers separated by a
hairless mouse skin was filled with a cosmetic having
the composition described in Table 6 and the other

(receiver side) was filled with a phosphate buffer
solution (pH 7). After 5 hours, the concentration of
methylparaben on the receiver side was measured. Table
7 shows the results.

As will be apparent from the results, the inventive
preparation showed a limited amount of skin penetration
of methylparaben, a skin-irritating substance.

31


CA 02333601 2000-11-28
I 1

Table 6

Inventive Inventive Comparative
Component($) preparation preparation preparation
1 2
Surfactin sodium salt 3.0 - -
Dried medium preparation - 3.0 -
Ethyl alcohol 39.6 39.6 39.6
1,3-Butylene glycol 9.5 9.5 9.5
Castor oil 4.9 4.9 4.9
Tocopherol 1.0 1.0 1.0
Methylparaben 0.2 0.2 0.2
Purified water Balance Balance Balance

Table 7

Test Substance Concentration of
methylparaben
Inventive preparation 1 3.5 ppm
Inventive preparation 2 3.6 ppm
Comparative preparation 7.0 ppm

Example 5

Samples were prepared by dissolving surfactin
sodium salt in a concentration of 0 or 0.2% and calcium
chloride dihydrate in a calcium concentration of 0, 10,
or 20 ppm in each of solvents described below, and each

solution was charged in a screw vial and sealed, which
was then left to stand at 40t for 7 days. After 7 days,
32


CA 02333601 2000-11-28
1 )

the turbidity of each sample was judged visually. Table
8 shows the results.

Solvent 1: Deionized water

Solvent 2: 7% Ethanol, 93% deionized water

Solvent 3: 7$ Ethanol, 5$ glycerin, 5% 1,3-butylene
glycol, 83$ deionized water

Table 8

Concentration of
Composition of Samples calcium(ppm)
0 10 20
Solvent 1 + Surfactin 0% - - -
Solvent 2 + Surfactin 0$ - - -
Solvent 3 + Surfactin 0t - - -
Solvent 1 + Surfactin 0.2% - + +
Solvent 2 + Surfactin 0.2% - + +
Solvent 3 + Surfactin 0.2% - + +
Not turbid
+: Turbid

As will be apparent from the results in Table 8,
in solvents containing surfactin sodium salts,
turbidity occurs in the presence of calcium.

Example 6

Samples were prepared by dissolving 0.2% surfactin
sodium salt and magnesium chloride dihydrate in a
magnesium concentration of 0, 10, or 20 ppm in each of

33


CA 02333601 2000-11-28
1 }

solvents described below, and each solution was charged
in a screw vial and sealed, which was then left to stand
at 40r- for 7 days. After 7 days, the turbidity of each
sample was judged visually. Table 9 shows the results.
Solvent 1: Deionized water

Solvent 2: 7% Ethanol, 93% deionized water
Solvent 3: 7% Ethanol, 5% glycerin, 5% 1,3-butylene
glycol, 83% deionized water

Table 9
Concentration of
Composition of magnesium(ppm)
Samples 0 10 20
Solvent 1 - + +
Solvent 2 - + t
Solvent 3 -
Not turbid
Slightly turbid
+: Turbid

As will be apparent from the results in Table 9,
in solvents containing surfactin sodium salts,
turbidity occurs in the presence of magnesium.

Example 7

Samples were prepared by dissolving 0.2$ surfactin
sodium salt and calcium chloride dihydrate in a calcium
concentration of 0.1, 1, or 10 ppm in the solvent
described below and further disodium edetate was added

34


CA 02333601 2000-11-28

in an amount of 0, 0. 0001 , 0.001, 0. 01 , 0.1, 0.2, 1, or
3%, respectively. Then, each solution was charged in
a screw vial and sealed, which was then left to stand
at 40'C for 7 days. After 7 days, the turbidity of each

sample was judged-visually. Table 10 shows the results.
Solvent: 7% Ethanol, 5% glycerin, 5% 1,3-butylene
glycol, 83% deionized water.

Table 10

Concentration of Concentration of calcium(ppm)
sodium edetate(%) 0.1 1 10

0 - + +
0.0001 - f +
0.001 - - +
0.01 - - -
0.1 - - -
0.2 - - -
1 - - -
3 - - -
Not turbid
: Slightly turbid
+: Turbid

As will be apparent from the results in Table 10,
in solvents containing surfactin sodium salt and
calcium, addition of disodium edetate prevented
turbidity from occurring.



CA 02333601 2000-11-28
1 ;
Example 8

Samples were prepared by dissolving 0.2% surfactin
sodium salt and calcium chloride dihydrate in a calcium
concentration of 0.1, 1, or 10 ppm in the solvent

described below and further sodium citrate was added in
an amount of 0, 0.0001, 0.001, 0.01, 0.1, 0.2, 1, or 3%,
respectively. Then, each solution was charged in a screw
vial and sealed, which was then left to stand at 40r-
for 7 days. After 7 days, the turbidity of each sample
was judged visually. Table 11 shows the results.

Solvent: 7% Ethanol, 5% glycerin, 5% 1,3-butylene
glycol, 83% deionized water.

Table 11

Concentration of Concentration of calcium(ppm)
sodium citrate(t) 0.1 1 10

0 - + -}-
0.0001 - f +
0.001 - - +
0.01 - - -
0.1 - - -
0.2 - - -
1 - - -
3 - - -
Not turbid
: Slightly turbid
+: Turbid

36


CA 02333601 2000-11-28
1 1
As will be apparent from the results in Table 11,
in solvents containing surfactin sodium salt and
calcium, addition of sodium citrate is effective in
inhibiting the occurrence of turbidity, similarly to
disodium edetate.

Example 9

Milky lotions having the composition shown in Table
12 were prepared and were evaluated for their skin

irritation. In the same manner as in Example 1, a skin
model was exposed to each of the prepared test substances
(milky lotions described in Table 12) for 1 hour.
Thereafter, the test substance was washed and incubated
in the above-described medium for 16 hours. After the

incubation, a MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) was added, and pigments
were extracted with isopropanol rendered acidic with
hydrochloric acid, followed by measurement of

absorbance and calculation of cytotoxicity. The

cytotoxicity was calculated according to the equation
described in Example 1. Table 13 shows cytotoxicity of
the test substances.

37


CA 02333601 2000-11-28
0

(-I ro N I O 1 1 O ~ ~ ~ ~ b ~~ M O O O
ri
0 N
U a
O
E ~ M 9"4 O O r- O r-1
cd
O f-1
U a
A
~
~ f~-I 0 %O d' d'
~ a ch o~ o o o~
H 0
co
$4

N q
r-i ~ =O ~
+J R1 O '~ ~D d' v
4) (11 O O O
.-i
~d 'J a O .-1 '-I
F

~ o
+~ o o
> o ~ r-I o
H (-I

~ = r1 4)
,i ro o o %c 10 '-' er ~
. . ' .
~ tda M ~ o C) o ri
H Sd

4'
r- o
(a "H
,, ~--1
0
0
. 'P..
r= a 4 ,' r-I ~
a
41 =rl CO G) 0 b1 S-i
r. ~o a 4J r. m
o m ~
~ ai ~ ~ 0 o a 3
)
~ =~ ~ E v 0 0 b >4 b
U b 9 E cd G Li ~ E W
'b
W 0 =.-1 O 0) R1 1 44 =rl
S 0 > G) +1 M
~ ~ C) 0
cn ca A En a 94 Cn .-, a a
38


CA 02333601 2000-11-28

Table13
Test Substance Cytotoxicity
Inventive preparation 1 0.0 $
Inventive preparation 2 0.0 $
Inventive preparation 3 0.0 -%
Inventive preparation 4 0.0 %
Comparative preparation 1 0.0 %
Comparative preparation 2 0.0 %

As will be apparnt from the results shown in Table
13, the inventive preparation like the comparative
preparations had very low sin irritation and the

addition of disodium edetate or sodium citrate did not
affect on the low irritation.

Example 10

One (donor side) of two chambers separated by a
hairless mouse skin was filled with a cosmetic having
the composition described in Table 14 and the other
(receiver side) was filled with a phosphate buffer
solution (pH 7). After 5 hours, the concentration of
methylparaben on the receiver side was measured. Table
15 shows the results.

39


CA 02333601 2000-11-28
1 ~
C)
Iff m O N ~.,
1C) t . . . . ~
~
0
-H O 1~ LO ON 0 N
~ = 1 1 . . . b
4J M M O+ r-1 O '-1
ld
a
a~ m
ti
a o LO O% O N ~
; M ~ 1 1 1 M O' ~ ri O ~
=ri (~
4J
ld
N O
~
~ N 1 1 1 O to O% o N ro
0 o rn er .1 O ~
m
%D
b
O M ~ =-1 O r-I
R~

O 1 0 LO O% O N ~
~ M O 11 O~ eN .i O ~
E tc1
O
0

4J M o 1 1 C) LO 4m 0 N ro
a e') oi o+
a~ aa
ti
P4
a~ m
LO
O~ O N ~7
rl N , O = Id
4J
M O ri ' -0 .-1 O r1
O b
> A
H
C)
O 0 LA O~ O N
= ' = . . = ~
M 0 M O~ i O ~-1
b
~ O
.. ,~ +J
t0 41 N
0 m O m
to m Id O [ ri O ++

-I
~~ O ~i U ~ ~ m f0 3
rl m+1 ~ U .-1 4J 0 N 'd
E ~ ~i ro b 5.-a M 0 N o a~
0 w +J 0 a o =.~ >I 1 u + J O .c ~
U H rl =ri 0 m 'Lf .T~' cn 'J+ t11 E +1 f-1
Id f H N=H 0 +J .~-i cd 1 y
VI tA A W A [A W ~ b~ U tl ~ W


CA 02333601 2000-11-28

Table 15

Concentration of
Test Substance
methyiparaben
Inventive preparation 1 3.6 ppm
Inventive preparation 2 3.7 ppm
Inventive preparation 3 3.5 ppm
Inventive preparation 4 3.6 ppm
Comparative preparation 1 7.2 ppm
Comparative preparation 2 7.1 ppm
Comparative preparation 3 3.5 ppm
Comparative preparation 4 3.6 ppm
Comparative preparation 5 7.0 ppm

As will be apparent from the results, the inventive
preparation like the comparative preparations 3 and 4
suppressed the skin penetration of methylparaben, a

skin-irritating substance. Therefore, it revealed that
the addition of disodium edetate or sodium citrate did
not affect on the effect of reducing the irritation of
skin-irritating substances.

Formulation Examples

In the following formulation examples of external
preparation for skin, APM and APS indicate magnesium
ascorbic acid 2-phosphate and sodium ascorbic acid
2-phosphate. Also, "$" means "wt%".


Formulation Example 1: Beauty wash
41


CA 02333601 2000-11-28

The following components were dissolved with
heating at 50'C and cooled with stirring until the
temperature reached 30cC when the stirring was stopped
and left to stand to prepare a beauty wash.

Ethyl alcohol 39.6%
1,3-Butylene glycol 9.54;
Castor oil 4.9%
a-Tocopherol 1.0%
Magnesium ascorbic 2-phosphate 1.0%

Sodium ascorbic 2-phosphate 1.0%
Methylparaben 0.2%
Surfactin 1 . 0%
Purified water balance

Formulation Example 2: Milky lotion

The following components were dissolved with
heating at 80'C with stirring to emulsify. This was
cooled with stirring and the stirring was stopped at
40'C , and the mixture was left to stand to prepare a milky
lotion.

Avogado oil 11.0%
Behenyl alcohol 0.6%
Stearic acid 0.4%
Glycerin fatty acid ester 0.9%
Polyoxyethylene sorbitan fatty

acid ester 1.1$
42


CA 02333601 2000-11-28

Polyoxyethylene alkyl ether 0.4%
a-Tocopherol 1.0%
Magnesium ascorbic 2-phosphate 1.0%
Sodium ascorbic 2-phosphate 1.0%

1,3-Butylene glycol 10.1%
Methylparaben 0.2$
Perfume 0 . 4 $
Surfactin 0 . 5$
Purified water balance


Formulation Example 3: Cream

The following components were dissolved with
heating at 80r- with stirring to emulsify. This was
cooled with stirring and the stirring was stopped at

40'C, and the mixture was left to stand to prepare a
cream.

Squalane 11.1%
Stearic acid 7.8%
Stearyl alcohol 6.0%

Beeswax 1.9%
Propylene glycol monostearate 3.1%
Polyoxyethylene cetyl ether 1.1%
a-Tocopherol 1.0%
Magnesium ascorbic 2-phosphate 1.0%

Sodium ascorbic 2-phosphate 1.0%
1,3-Butylene glycol 10.1%
43


CA 02333601 2000-11-28
1 ~

Methylparaben 0.2%
Perfume 0 . 4$
Surfactin 0 . 5$
Purified water balance


Formulation Example 4: Pack

The following components were swelled with heating
at 50'C and uniformly mixed with stirring. This was
cooled with stirring and the stirring was stopped at

300C, and the mixture was left to stand to prepare a pack.
Polyvinyl alcohol 14.5$

Sodium carboxymethylcellulose 4.8%
1,3-Butylene glycol 2.9%
a-Tocopherol 1.0%

Magnesium ascorbic 2-phosphate 1.0%
Sodium ascorbic 2-phosphate 1.0$
Ethyl alcohol 10.0%
Methylparaben 0.1%
Surfactin 0 . 5 %

Purified water balance
Formulation Example 5: Lipstick

A red pigment was dispersed in castor oil using a
roll mill to prepare a dispersion (A) . To the dispersion
were dissolved with heating other blending components

in the following proportions and mixed well. The mixture
44


CA 02333601 2000-11-28
1 ,

was filtered and cast in a mold at a high temperature
and cooled. The molded composition was charged in a
vessel to prepare a lipstick.

Castor oil 45.3%
Hexadecyl alcohol 25.2$
Lanoline 3.9
Beeswax 4.8%
Ozocerite 3.4%
Candelilla wax 6.2%

Carnauba wax 2.1%
Methylparaben 0.1%
a-Tocopherol 1.0%
Magnesium ascorbic 2-phosphate 1.0%
Sodium ascorbic 2-phosphate 1.0%

Titanium oxide 2.1%
Red pigment 4.8%
Perfume 0.1%
Surfactin 0.1%
Moisture balance


Formulation Example 6: Beauty wash

The following components were dissolved with
heating at 50cC and cooled with stirring. The stirring
was stopped at 30r, and the mixture was left to stand
to prepare a beauty wash.

Ethyl alcohol 39.6%


CA 02333601 2000-11-28

1,3-Butylene glycol 9.5%
Castor oil 4.9%
a-Tocopherol 1.0%
APM or APS 3.0%

Kojic acid 1.0%
Placenta extract 1.0%
Albutin 1.0%
Citric acid 0.5%
Tartaric acid 0.5%

Malic acid 0.5%

NaOH (s. a. to make weakly alkaline pH)
Methylparaben 0.2$
Surfactin 0 . 5$

Purified water balance

Formulation Example 7: Beauty wash

The following components were dissolved with
heating at 50r- and cooled with stirring. The stirring
was stopped at 301C, and the mixture was left to stand
to prepare a beauty wash.

Ethyl alcohol 39.6%
1,3-Butylene glycol 9.5%
Castor oil 4.9-t
a-Tocopherol 1.0%

APM or APS 3.0%
Kojic acid 1.0%
46


CA 02333601 2000-11-28

Placenta extract 1.04k
Albutin 1.0$
Citric acid 0.5%
Tartaric acid 0.5%

Malic acid 0.5%
EDTA 2Na 1.0%

NaOH (s. a. to make weakly alkaline pH)
Methylparaben 0.2%
Surfactin 0.5%
Purified water balance

Formulation Example 8: Beauty wash

The following components were dissolved with
heating at 50~C and cooled with stirring. The stirring
was stopped at 30r, and the mixture was left to stand
to prepare a beauty wash.

Ethyl alcohol 39.6%
1,3-Butylene glycol 9.54;
Castor oil 4.9t

APM or APS 3.0$
Methylparaben 0.2%
Surfactin 0.5*
Purified water balance

Formulation Example 9: Milky lotion
47


CA 02333601 2000-11-28

The following components were dissolved with
heating at 80t with stirring to emulsify. This was
cooled with stirring and the stirring was stopped at
40r,, and the mixture was left to stand to prepare a milky
lotion.

Avogado oil 11.0%
Behenyl alcohol 0.6$
Stearic acid 0.4%
Glycerin fatty acid ester 0.9%
Polyoxyethylene sorbitan fatty

acid ester 1.1%
Polyoxyethylene alkyl ether 0.4%
APM or APS 3.0%
1,3-Butylene glycol 10.1%

Methylparaben 0.2%
Perfume 0.4%
Surfactin 0.5%
Purified water balance

Formulation Example 10: Cream

The following components were dissolved with
heating at 80r- with stirring to emulsify. This was
cooled with stirring and the stirring was stopped at
40'C, and the mixture was left to stand to prepare a
cream.

Squalane 11.1%
48


CA 02333601 2000-11-28

Stearic acid 7.8%
Stearyl alcohol 6.0%
Beeswax 1.9%
Propylene glycol monostearate 3.1%

Polyoxyethylene cetyl ether 1.1%
APM or APS 3.01%
1,3-Butylene glycol 11.9%
Methylparaben 0.2%
Perfume 0.4%

Surfactin 1 . 0%
Purified water balance
Formulation Example 11: Pack

The following components were swelled with heating
at 50r and uniformly mixed with stirring. This was
cooled with stirring and the stirring was stopped at
30r, and the mixture was left to stand to prepare a pack.
Polyvinyl alcohol 14.5%

Sodium carboxymethylcellulose 4.8%
1,3-Butylene glycol 2.9%
APM or APS 3.0%
Ethyl alcohol 10.0%
Ethylparaben 0.1%
Surfactin 0.1%

Purified water balance
49
---------- ------ ----


CA 02333601 2000-11-28

Formulation Example 12: Lipstick

A red pigment was dispersed in castor oil using a
roll mill to prepare a dispersion (A) . To the dispersion
were dissolved with heating other blending components

in the following proportions and mixed well. The mixture
was filtered and cast in a mold at a high temperature
and cooled. The molded composition was charged in a
vessel to prepare a lipstick.

Castor oil 45.3%
Hexadecyl alcohol 25.2%
Lanoline 3.9%
Beeswax 4.8%
Ozocerite 3.4%
Candelilla wax 6.2%

Carnauba wax 2.1%
Methylparaben 0.1%
APM or APS 3.0$
Titanium oxide 2.1-t
Red pigment 4.8%

Perfume 0.1%
Surfactin 0 . 1$
Moisture balance

Formulation Example 13: Foundation

The following components were mixed at 80t with
stirring and then left to cool to prepare a foundation.


CA 02333601 2000-11-28

Liquid paraffin 23.5%
Isopropyl palmitate 14.3%
Lanoline alcohol 1.8%
Lanoline acetate 2.9%

Microcrystalline wax 6.5%
Ozocerite 7.7%
Candelilla wax 0.4%
Methylparaben 0.1$
APM or APS 3.0$

Titanium oxide 14.5%
Kaolin 13.9%
Talc 5.7%
Coloring pigment 3.9%
Perfume 0.5%

Surfactin 0.1%
Moisture balance
Formulation Example 14: Dentifrice

The following compositions were swelled with

heating, mixed well, and then left to stand to prepare
a dentifrice composition.

Calcium secondary phosphate

dihydrate 45.5%
Sodium carboxymethylcellulose 0.5$
Carrageenan 0.5%

Glycerin 9.8%
51


CA 02333601 2000-11-28
j i

Sorbitol 9.7%
Sodium saccharinate 0.1%
Surfactin 2.0%
Sodium chloride 2.1$

a-Tocopherol 0.4$
APM or APS 3.0-%
Antiseptic 0.1-%
Perfume 0 . 5 $
Purified water balance


Formulation Example 15: Gargle

The following components were uniformly mixed at
ambient temperature to prepare a gargle.

Ethyl alcohol 34.6%
Glycerin 14.5%
a-Tocopherol 0.4%
APM or APS 3.0%
Surfactin 0.1%
Perfume 0.5%

Purified water balance
Formulation Example 16: Hair tonic

The following components were uniformly mixed at
ambient temperature to prepare a hair tonic.

Ethyl alcohol 63.0%
Castor oil 4.3%
52


CA 02333601 2000-11-28

Resorcinol 0.7%
Methylparaben 0.1%
Capsicum tincture 0.4%
a-Tocopherol 0.4%

APM or APS 3.0%
Surfactin 0 . 2%
Purified water balance

Formulation Example 17: Shampoo

The following components were dissolved by heating
at 70r and mixed with stirring. Then this was cooled
with stirring to 40t and left to stand to prepare a
shampoo.

Triethanolamine laurylsulfate 15.0$
Diethanolamide laurate 3.3%
Triethanolamine polyacrylate 0.3%
Zinc pyridinium-l-thiol-N-oxide 1.1%
APM or APS 3.0%
Surfactin 1 . 0$

Pigment minute amount
Perfume 0 . 5$

Purified water balance
Formulation Example 18: Rinse

The following components were dissolved by heating
at 80t and mixed with stirring. Then this was cooled
53


CA 02333601 2000-11-28

with stirring to 40r- and left to stand to prepare a
rinse.

Stearyldimethylbenzylammonium
chloride 1.4%
Stearyl alcohol 0.6-t

Glyceryl monostearate 1.5%
Sodium chloride 0.2%
APM or APS 3.0%
Surfactin 0 . 1$

Purified water balance
Formulation Example 19: Bath agent

The following components were uniformly mixed at
ambient temperature to prepare a bath agent.

Sodium hydrogen carbonate 35.5%
Citric acid 37.1%
Polyethylene glycol 2.1%
Magnesium chloride 1.1%
a-Tocopherol 0.5%

APM or APS 24.0%
Surfactin 1 . 0$

Pigment minute amount
Perfume 2 . 0%

Formulation Example 20: Beauty wash
54


CA 02333601 2000-11-28

The following components were dissolved with
heating at 50r and cooled with stirring. The stirring
was stopped at 30'C, and the mixture was left to stand
to prepare a beauty wash.

Ethyl alcohol 39.6%
1,3-Butylene glycol 9.5%
Castor oil 4.9%
a-Tocopherol 1.0%
Magnesium ascorbic 2-phosphate 1.0%

Sodium ascorbic 2-phosphate 1.0$
Methylparaben 0.2%
Surfactin 1 . 0$
Disodium edetate 0.01%
Purified water balance

Formulation Example 21: Milky lotion

The following components were dissolved with
heating at 80t with stirring to emulsify. This was
cooled with stirring and the stirring was stopped at

40'C , and the mixture was left to stand to prepare a milky
lotion.

Avogado oil 11.0%
Behenyl alcohol 0.6%
Stearic acid 0.4-t

Glycerin fatty acid ester 0.9%
Polyoxyethylene sorbitan fatty



CA 02333601 2000-11-28

acid ester 1.1%
Polyoxyethylene alkyl ether 0.4%
a-Tocopherol 1.0%
Magnesium ascorbic 2-phosphate 1.0%

Sodium ascorbic 2-phosphate 1.0%
1,3-Butylene glycol 10.1%
Methylparaben 0.2$
Perfume 0 . 4 $
Surfactin 0.5%

Disodium edetate 0.01%
Purified water balance
Formulation Example 22: Cream

The following components were dissolved with

heating at 80r with stirring to emulsify. This was
cooled with stirring and the stirring was stopped at
409C, and the mixture was left to stand to prepare a
cream.

Squalane 11.1%
Stearic acid 7.8%
Stearyl alcohol 6.0%
Beeswax 1.9%
Propylene glycol monostearate 3.1%
Polyoxyethylene cetyl ether 1.1%

a-Tocopherol 1.0%
Magnesium ascorbic 2-phosphate 1.0%
56


CA 02333601 2000-11-28

Sodium ascorbic 2-phosphate 1.0%
1,3-Butylene glycol 10.1%
Methylparaben 0.2$
Perfume 0 . 4$

Surfactin 0.5%
Sodium citrate 0.01%
Purified water balance

Formulation Example 23: Pack

The following components were swelled with heating
at 50'C and uniformly mixed with stirring. This was
cooled with stirring and the stirring was stopped at
30r, and the mixture was left to stand to prepare a pack.
Polyvinyl alcohol 14.5%

Sodium carboxymethylcellulose 4.8%
1,3-Butylene glycol 2.9%
a-Tocopherol 1.0$
Magnesium ascorbic 2-phosphate 1.0%
Sodium ascorbic 2-phosphate 1.0%

Ethyl alcohol 10.0%
Methylparaben 0.1%
Surfactin 0 . 5$
Sodium citrate 0.01%
Purified water balance

Formulation Example 24: Lipstick
57


CA 02333601 2000-11-28
1 ~

A red pigment was dispersed in castor oil using a
roll mill to prepare a dispersion (A). To the dispersion
were dissolved with heating other blending components
in the following proportions and mixed well. The mixture

was filtered and cast in a mold at a high temperature
and cooled. The molded composition was charged in a
vessel to prepare a lipstick.

Castor oil 45.3%
Hexadecyl alcohol 25.2%
Lanoline 3.9$

Beeswax 4.8$
Ozocerite 3.4%
Candelilla wax 6.2%
Carnauba wax 2.1%

Methylparaben 0.1%
a-Tocopherol 1.0%
Magnesium ascorbic 2-phosphate 1.0$
Sodium ascorbic 2-phosphate 1.0%
Titanium oxide 2.1%

Red pigment 4.8%
Perfume 0 . 1$
Surfactin 0.1%
Disodium edetate 0.005%
Moisture balance

Formulation Example 25: Beauty wash
58


CA 02333601 2000-11-28

The following components were dissolved with
heating at 50r and cooled with stirring. The stirring
was stopped at 30'C, and the mixture was left to stand
to prepare a beauty wash.

Ethyl alcohol 39.6$
1,3-Butylene glycol 9.5%
Castor oil 4.9%
APM or APS 3.0$
Sodium citrate 0.1%

Methylparaben 0.2%
Surfactin 0.5%
Purified water balance

Formulation Example 26: Milky lotion

The following components were dissolved with
heating at 80'C with stirring to emulsify. This was
cooled with stirring and the stirring was stopped at
40'C , and the mixture was left to stand to prepare a milky
lotion.

Avogado oil 11.0$
Behenyl alcohol 0.6$
Stearic acid 0.4%
Glycerin fatty acid ester 0.9%
Polyoxyethylene sorbitan fatty

acid ester 1.1%
Polyoxyethylene alkyl ether 0.4%
59


CA 02333601 2000-11-28

APM or APS 3.0%
1,3-Butylene glycol 10.1%
Disodium edetate 0.01%
Methylparaben 0.2%

Perfume 0.4%
Surfactin 0 . 5$
Purified water balance

Formulation Example 27: Cream

The following components were dissolved with
heating at 80r with stirring to emulsify. This was
cooled with stirring and the stirring was stopped at
40'C, and the mixture was left to stand to prepare a
cream.

Squalane 11.1%
Stearic acid 7.8%
Stearyl alcohol 6.0%
Beeswax 1.9-t
Propylene glycol monostearate 3.1$

Polyoxyethylene cetyl ether 1.1%
APM or APS 3.0%
1,3-Butylene glycol 11.9%
Disodium edetate 0.01%
Methylparaben 0.2%

Perfume 0 . 4 $
Surfactin 1 . 0%


CA 02333601 2000-11-28

Purified water balance
Formulation Example 28: Pack

The following components were swelled with heating
at 50r- and uniformly mixed with stirring. This was
cooled with stirring and the stirring was stopped at
30r, and the mixture was left to stand to prepare a pack.
Polyvinyl alcohol 14.5%

Sodium carboxymethylcellulose 4.8$
1,3-Butylene glycol 2.9%
APM or APS 3.0%
Ethyl alcohol 10.0%
Disodium edetate 0.001-t
Ethylparaben 0.11%

Surfactin 0 . 1%
Purified water balance
Formulation Example 29: Lipstick

A red pigment was dispersed in castor oil using a
roll mill to prepare a dispersion (A) . To the dispersion
were dissolved with heating other blending components
in the following proportions and mixed well. The mixture
was filtered and cast in a mold at a high temperature
and cooled. The molded composition was charged in a
vessel to prepare a lipstick.

Castor oil 45.3%
61


CA 02333601 2000-11-28

Hexadecyl alcohol 25.2%
Lanoline 3.9%
Beeswax 4.8%
Ozocerite 3.4%

Candelilla wax 6.2%
Carnauba wax 2.1%
Methylparaben 0.1%
APM or APS 3.0%
Titanium oxide 2.1%

Red pigment 4.8%
Perfume 0 . 1%
Edetic acid 0.001%
Surfactin 0.1%
Moisture balance

Formulation Example 30: Foundation

The following components were mixed at 809C with
stirring and then left to cool to prepare a foundation.
Liquid paraffin 23.5%

Isopropyl palmitate 14.3%
Lanoline alcohol 1.8%
Lanoline acetate 2.9%
Microcrystalline wax 6.5%
Ozocerite 7.7%

Candelilla wax 0.4%
Methylparaben 0.1%
62


CA 02333601 2000-11-28
i 1

APM or APS 3.0%
Titanium oxide 14.5%
Kaolin 13.9%
Talc 5.7%

Coloring pigment 3.9%
Perfume 0 . 5-W
Disodium edetate 0.001%
Surf actin 0 . 1$
Moisture balance

Formulation Example 31: Dentifrice

The following compositions were swelled with
heating, mixed well, and then left to stand to prepare
a dentifrice composition.

Calcium secondary phosphate

dihydrate 45.5%
Sodium carboxymethylcellulose 0.5%
Carrageenan 0.5%
Glycerin 9.8%

Sorbitol 9.7%
Sodium saccharinate 0.1%
Surfactin 2 . 0%
Sodium chloride 2.1%
a-Tocopherol 0.4%

APM or APS 3.0%
Disodium edetate 0.1%
63


CA 02333601 2000-11-28

Antiseptic 0.1%
Perfume 0 . 5$
Purified water balance

Formulation Example 32: Gargle

The following components were uniformly mixed at
ambient temperature to prepare a gargle.

Ethyl alcohol 34.6.1
Glycerin 14.5%
a-Tocopherol 0.4%

APM or APS 3.0%
Sodium citrate 0.01%
Surfactin 0 . 14;
Perfume 0 . 5 $

Purified water balance
Formulation Example 33: Hair tonic

The following components were uniformly mixed at
ambient temperature to prepare a hair tonic.

Ethyl alcohol 63.0%
Castor oil 4.3%
Resorcinol 0.7%
Methylparaben 0.1$
Capsicum tincture 0.4%

a-Tocopherol 0.4%
APM or APS 3.0%
64


CA 02333601 2000-11-28
1 ~

Disodium edetate 0.01%
Surfactin 0.2%
Purified water balance

Formulation Example 34: Shampoo

The following components were dissolved by heating
at 70r and mixed with stirring. Then this was cooled
with stirring to 40t and left to stand to prepare a
shampoo.

Triethanolamine laurylsulfate 15.0%
Diethanolamide laurate 3.3%
Triethanolamine polyacrylate 0.3$
Zinc pyridinium-l-thiol-N-oxide 1.1%
APM or APS 3.0%

Disodium edetate 0.05%
Surfactin 1 . 0$

Pigment minute amount
Perfume 0 . 5$

Purified water balance

Formulation Example 35: Rinse

The following components were dissolved by heating
at 809C and mixed with stirring. Then this was cooled
with stirring to 40r- and left to stand to prepare a
rinse.

Stearyldimethylbenzylammonium


CA 02333601 2000-11-28

chloride 1.4%
Stearyl alcohol 0.6%
Glyceryl monostearate 1.5%
Sodium chloride 0.2%

APM or APS 3.0-t
Disodium edetate 0.001-W
Surfactin 0 . 1$
Purified water balance

Formulation Example 36: Bath agent

The following components were uniformly mixed at
ambient temperature to prepare a bath agent.

Sodium hydrogen carbonate 35.5%
Citric acid 37.1%
Polyethylene glycol 2.1-t

Magnesium chloride 1.1%
a-Tocopherol 0.5%
APM or APS 24.0%
Disodium edetate 1.0%

Surfactin 0 , 2$

Pigment minute amount
Perfume 2.0%
66


CA 02333601 2000-11-28

INDUSTRIAL APPLICABILITY

The surf actant for use in external preparations for
skin of the present invention has low skin penetration
and low skin irritation. Therefore, they can be applied
to cosmetics. Cosmetics usually contain skin-

irritating substances and addition of the surfactant of
the present invention can reduce the irritation of the
irritating substances.

Surfactin, a typical example of the surfactant for
use in external preparations for skin, can be produced
by utilizing microbes so that it is advantageous from
the viewpoint of production method.

Further, the external preparation for skin
containing a sequestering agent according to the present
invention can suppress the generation of turbidity in

cosmetics attributable to the surfactant for use in
external preparations for skin and alkaline earth metal
and can retain transparency of cosmetics. Therefore,
it is very advantageous in its application to

transparent cosmetics.

67

Representative Drawing

Sorry, the representative drawing for patent document number 2333601 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 2008-02-05
(86) PCT Filing Date 1999-05-28
(87) PCT Publication Date 1999-12-09
(85) National Entry 2000-11-28
Examination Requested 2004-05-18
(45) Issued 2008-02-05
Expired 2019-05-28

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Registration of a document - section 124 $100.00 2000-11-28
Application Fee $300.00 2000-11-28
Maintenance Fee - Application - New Act 2 2001-05-28 $100.00 2000-11-28
Maintenance Fee - Application - New Act 3 2002-05-28 $100.00 2002-05-15
Maintenance Fee - Application - New Act 4 2003-05-28 $100.00 2003-05-20
Request for Examination $800.00 2004-05-18
Maintenance Fee - Application - New Act 5 2004-05-28 $200.00 2004-05-25
Maintenance Fee - Application - New Act 6 2005-05-30 $200.00 2005-05-13
Maintenance Fee - Application - New Act 7 2006-05-29 $200.00 2006-05-15
Maintenance Fee - Application - New Act 8 2007-05-28 $200.00 2007-05-28
Final Fee $300.00 2007-11-21
Maintenance Fee - Patent - New Act 9 2008-05-28 $200.00 2008-05-14
Maintenance Fee - Patent - New Act 10 2009-05-28 $250.00 2009-04-20
Registration of a document - section 124 $100.00 2009-11-19
Maintenance Fee - Patent - New Act 11 2010-05-28 $250.00 2010-04-14
Maintenance Fee - Patent - New Act 12 2011-05-30 $250.00 2011-04-13
Maintenance Fee - Patent - New Act 13 2012-05-28 $250.00 2012-04-11
Maintenance Fee - Patent - New Act 14 2013-05-28 $250.00 2013-04-10
Maintenance Fee - Patent - New Act 15 2014-05-28 $450.00 2014-04-09
Maintenance Fee - Patent - New Act 16 2015-05-28 $450.00 2015-05-06
Maintenance Fee - Patent - New Act 17 2016-05-30 $450.00 2016-05-04
Maintenance Fee - Patent - New Act 18 2017-05-29 $450.00 2017-05-03
Maintenance Fee - Patent - New Act 19 2018-05-28 $450.00 2018-05-02
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
KANEKA CORPORATION
Past Owners on Record
FURUYA, KAZUO
ITO, SHINOBU
KATO, EIKO
MIYOTA, YOSHIAKI
SHOWA DENKO K.K.
TAKAMA, MICHIHIRO
TSUZUKI, TOSHI
YONEDA, TADASHI
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Description 2000-11-28 67 1,763
Cover Page 2001-03-22 1 39
Abstract 2000-11-28 1 60
Claims 2000-11-28 4 122
Claims 2007-03-26 2 56
Cover Page 2008-01-16 1 34
Assignment 2009-11-19 2 108
Correspondence 2001-03-05 1 26
Assignment 2000-11-28 4 126
PCT 2000-11-28 12 339
Prosecution-Amendment 2000-11-28 1 19
Assignment 2001-04-17 4 148
Correspondence 2001-05-30 1 21
Correspondence 2001-06-08 1 43
Fees 2003-05-20 1 52
Fees 2002-05-15 1 51
Prosecution-Amendment 2006-10-10 2 60
Prosecution-Amendment 2004-05-18 1 48
Fees 2004-05-25 1 52
Prosecution-Amendment 2004-06-09 1 28
Fees 2005-05-13 1 55
Fees 2006-05-15 1 50
Prosecution-Amendment 2007-03-26 4 127
Fees 2007-05-28 1 55
Correspondence 2007-11-21 1 56
Fees 2008-05-14 1 59
Correspondence 2013-04-11 4 202
Assignment 2013-02-26 6 318
Assignment 2013-04-16 7 335